Canada Immunoglobulins Market Size, Share & Industry Analysis, By Product Type (Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIg)), By Indication (Primary Immunodeficiency (PI), Secondary Immunodeficiency (SID), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP), Guillain Barré Syndrome and Others), By End User (Hospitals & ASCs, Specialty Clinics and Others), and Forecasts, 2025-2032

Last Updated: December 29, 2025 | Format: PDF | Report ID: FBI114968

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Growth Takeaways in the Market
2. Overview: Evolution of Immunoglobulin Therapies in Canada
3. Analysis: Degree of Self Sufficiency, Immunoglobulins, CBS and Héma-Québec
4. Key Industry Development- Mergers, Acquisitions, Partnerships, Others
Canada Immunoglobulins Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Intravenous Immunoglobulin (IVIG)
  2. Subcutaneous Immunoglobulin (SCIg)
2. Market Analysis, Insights and Forecast – By Indication
  1. Primary Immunodeficiency (PI)
  2. Secondary Immunodeficiency (SID)
  3. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  4. Immune Thrombocytopenic Purpura (ITP)
  5. Guillain Barré Syndrome
  6. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & ASCs
  2. Specialty Clinics
  3. Others
Competitive Analysis
1. Canada Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Grifols, S.A.
  2. Octapharma AG
  3. CSL Behring LLC.
  4. Takeda Pharmaceutical Company Limited.
  5. Other Prominent Players

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Overview: Growth Takeaways in the Market
2. Overview: Evolution of Immunoglobulin Therapies in Canada
3. Analysis: Degree of Self Sufficiency, Immunoglobulins, CBS and Héma-Québec
4. Key Industry Development- Mergers, Acquisitions, Partnerships, Others
Canada Immunoglobulins Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product Type
  1. Intravenous Immunoglobulin (IVIG)
  2. Subcutaneous Immunoglobulin (SCIg)
2. Market Analysis, Insights and Forecast – By Indication
  1. Primary Immunodeficiency (PI)
  2. Secondary Immunodeficiency (SID)
  3. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  4. Immune Thrombocytopenic Purpura (ITP)
  5. Guillain Barré Syndrome
  6. Others
3. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & ASCs
  2. Specialty Clinics
  3. Others
Competitive Analysis
1. Canada Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. Grifols, S.A.
  2. Octapharma AG
  3. CSL Behring LLC.
  4. Takeda Pharmaceutical Company Limited.
  5. Other Prominent Players